Literature DB >> 22676571

Evolution of concept, but not action, in addiction treatment.

Amelia M Arria1, A Thomas McLellan.   

Abstract

The Western approach to addiction treatment involves a medical or disease orientation to understanding the onset, course, and management of addiction, and a clinical goal of abstinence or very significant reductions in drug use, usually with a combination of behavioral and pharmacological interventions. Even within this Western approach, and despite several consensually accepted features of addiction, a significant mismatch remains between what this culture has come to accept as the nature of the disease and how that same culture continues to treat the disease. This paper discusses the evolution of these Western concepts over the past decade without a corresponding evolution in the nature, duration, or evaluation standards for addiction treatment. (1) Here, we take the position that continuing care and adaptive treatment protocols, combining behavioral therapies, family and social supports, and, where needed, medications show much promise to address the typically chronic, relapsing, and heterogeneous nature of most cases of serious addiction. By extension, methods to evaluate effectiveness of addiction treatment should focus upon the functional status of patients during the course of their treatment instead of post-treatment, as is the evaluation practice used with most other chronic illnesses.

Entities:  

Mesh:

Year:  2012        PMID: 22676571      PMCID: PMC3375602          DOI: 10.3109/10826084.2012.663273

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  35 in total

1.  From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol.

Authors:  Fernando A Wagner; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

Review 2.  Have we evaluated addiction treatment correctly? Implications from a chronic care perspective.

Authors:  A Thomas McLellan
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

Review 3.  Changing the focus: the case for recognizing and treating cannabis use disorders.

Authors:  Michael Dennis; Thomas F Babor; M Christopher Roebuck; Jean Donaldson
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

Review 4.  The physician's role in caring for patients with substance use disorders: implications for medical education and training.

Authors:  David A Fiellin; Richard Butler; Gail D'Onofrio; Richard L Brown; Patrick G O'Connor
Journal:  Subst Abus       Date:  2002-09       Impact factor: 3.716

Review 5.  Pharmacologic treatment of heroin-dependent patients.

Authors:  P G O'Connor; D A Fiellin
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

6.  Integrating primary medical care with addiction treatment: a randomized controlled trial.

Authors:  C Weisner; J Mertens; S Parthasarathy; C Moore; Y Lu
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

7.  Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives.

Authors:  J H Samet; P Friedmann; R Saitz
Journal:  Arch Intern Med       Date:  2001-01-08

8.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

Review 9.  Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders.

Authors:  N S Miller; L M Sheppard; C C Colenda; J Magen
Journal:  Acad Med       Date:  2001-05       Impact factor: 6.893

10.  How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals.

Authors:  Constance Weisner; Helen Matzger; Lee Ann Kaskutas
Journal:  Addiction       Date:  2003-07       Impact factor: 6.526

View more
  9 in total

Review 1.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

2.  Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.

Authors:  Tessa Frohe; Cheryl L Beseler; Andres M Mendoza; Linda B Cottler; Robert F Leeman
Journal:  J Consult Clin Psychol       Date:  2019-10

3.  PTSD / substance use disorder comorbidity: Treatment options and public health needs.

Authors:  Lisa M Najavits; H Westley Clark; Carlo C DiClemente; Marc N Potenza; Howard J Shaffer; James L Sorensen; Matthew T Tull; Allen Zweben; Joan E Zweben
Journal:  Curr Treat Options Psychiatry       Date:  2020-09-24

Review 4.  Integrating time into stigma and health research.

Authors:  Valerie A Earnshaw; Ryan J Watson; Lisa A Eaton; Natalie M Brousseau; Jean-Philippe Laurenceau; Annie B Fox
Journal:  Nat Rev Psychol       Date:  2022-03-07

5.  Integration of parenting skills education and interventions in addiction treatment.

Authors:  Amelia M Arria; Amy A Mericle; Deanna Rallo; Jerry Moe; William L White; Ken C Winters; Garrett O'Connor
Journal:  J Addict Med       Date:  2013 Jan-Feb       Impact factor: 3.702

6.  Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.

Authors:  Elizabeth Evans; Howard Padwa; Libo Li; Veronique Lin; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2015-07-15

Review 7.  The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?

Authors:  Monica Malta; Michelle Ralil da Costa; Francisco Inácio Bastos
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

8.  Clinical and Research Implications of Gambling Disorder in DSM-5.

Authors:  Jeremiah Weinstock; Carla J Rash
Journal:  Curr Addict Rep       Date:  2014-06-13

9.  Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis.

Authors:  Meredith K Ginley; Rory A Pfund; Carla J Rash; Kristyn Zajac
Journal:  J Consult Clin Psychol       Date:  2021-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.